{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:37:10Z","timestamp":1770824230225,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.placenta.2017.02.011","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T16:09:58Z","timestamp":1486742998000},"page":"10-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Placental soluble fms-like tyrosine kinase expression in small for gestational age infants and risk for adverse outcomes"],"prefix":"10.1016","volume":"52","author":[{"given":"Melissa","family":"Spiel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saira","family":"Salahuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Pernicone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna","family":"Zsengeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"Modest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Ananth","family":"Karumanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9390","key":"10.1016\/j.placenta.2017.02.011_bib1","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(03)14466-2","article-title":"Chalmers J and surveillance of cerebral palsy in Europe collaboration of European cerebral palsy R. Cerebral palsy and intrauterine growth in single births: European collaborative study","volume":"362","author":"Jarvis","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.placenta.2017.02.011_bib2","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ajog.2005.10.816","article-title":"Customized versus population-based birth weight standards for identifying growth restricted infants: a French multicenter study","volume":"194","author":"Ego","year":"2006","journal-title":"Am. J. obstetrics Gynecol."},{"issue":"6","key":"10.1016\/j.placenta.2017.02.011_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ajog.2006.09.017","article-title":"Risk factors for antepartum and intrapartum stillbirth: a population-based study","volume":"196","author":"Getahun","year":"2007","journal-title":"Am. J. obstetrics Gynecol."},{"issue":"290","key":"10.1016\/j.placenta.2017.02.011_bib4","first-page":"e1","article-title":"Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study","volume":"208(4)","author":"Unterscheider","year":"2013","journal-title":"Am. J. obstetrics Gynecol."},{"issue":"4","key":"10.1016\/j.placenta.2017.02.011_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2350\/06-12-0203.1","article-title":"Placental lesions as predictors of cerebral palsy and abnormal neurocognitive function at school age in extremely low birth weight infants (<1 kg)","volume":"10","author":"Redline","year":"2007","journal-title":"Pediatr. Dev. Pathol."},{"issue":"5","key":"10.1016\/j.placenta.2017.02.011_bib6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2010.05.002","article-title":"Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort","volume":"157","author":"Zeitlin","year":"2010","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.placenta.2017.02.011_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4137\/CMPed.S40070","article-title":"Intrauterine growth restriction: antenatal and postnatal aspects","volume":"10","author":"Sharma","year":"2016","journal-title":"Clin. Med. Insights Pediatr."},{"issue":"24","key":"10.1016\/j.placenta.2017.02.011_bib8","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.placenta.2017.02.011_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"10","key":"10.1016\/j.placenta.2017.02.011_bib10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.placenta.2014.07.013","article-title":"Fetoplacental vascular alterations associated with fetal growth restriction","volume":"35","author":"Junaid","year":"2014","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.placenta.2017.02.011_bib11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.5858\/arpa.2011-0645-RA","article-title":"Hypoxic patterns of placental injury: a review","volume":"137","author":"Stanek","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"1","key":"10.1016\/j.placenta.2017.02.011_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0143-4004(84)80051-X","article-title":"Idiopathic intrauterine growth retardation: histomorphometry of the human placenta","volume":"5","author":"Teasdale","year":"1984","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.placenta.2017.02.011_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejogrb.2010.05.006","article-title":"Morphological characteristics of placentas associated with idiopathic intrauterine growth retardation: a clinicopathologic study","volume":"152","author":"Tomas","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.placenta.2017.02.011_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2431-13-59","article-title":"A\u00a0systematic review and meta-analysis to revise the Fenton growth chart for preterm infants","volume":"13","author":"Fenton","year":"2013","journal-title":"BMC Pediatr."},{"issue":"4","key":"10.1016\/j.placenta.2017.02.011_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ajog.2012.01.022","article-title":"Doppler assessment of the fetus with intrauterine growth restriction","volume":"206","author":"Berkley","year":"2012","journal-title":"Am. J. obstetrics Gynecol."},{"issue":"4 Suppl","key":"10.1016\/j.placenta.2017.02.011_bib16","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ajog.2015.05.056","article-title":"Classification of placental lesions","volume":"213","author":"Redline","year":"2015","journal-title":"Am. J. obstetrics Gynecol."},{"issue":"4 Pt 1","key":"10.1016\/j.placenta.2017.02.011_bib17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0029-7844(97)00360-8","article-title":"Placental vascular lesions and likelihood of diagnosis of preeclampsia","volume":"90","author":"Ghidini","year":"1997","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.placenta.2017.02.011_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/HYPERTENSIONAHA.111.182170","article-title":"Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"59","author":"Rajakumar","year":"2012","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.placenta.2017.02.011_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/10641955.2014.926914","article-title":"Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia","volume":"33","author":"Baltajian","year":"2014","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.placenta.2017.02.011_bib20","doi-asserted-by":"crossref","first-page":"291846","DOI":"10.1155\/2014\/291846","article-title":"Population-based placental weight ratio distributions","volume":"2014","author":"Macdonald","year":"2014","journal-title":"Int. J. Pediatr."},{"issue":"8","key":"10.1016\/j.placenta.2017.02.011_bib21","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.placenta.2014.04.019","article-title":"Obstetric conditions and the placental weight ratio","volume":"35","author":"Macdonald","year":"2014","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.placenta.2017.02.011_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/aje\/kwq373","article-title":"Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction","volume":"173","author":"Asvold","year":"2011","journal-title":"Am. J. Epidemiol."},{"issue":"2 Pt 1","key":"10.1016\/j.placenta.2017.02.011_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/AOG.0000000000000367","article-title":"Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction","volume":"124","author":"Herraiz","year":"2014","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.placenta.2017.02.011_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.11.015","article-title":"Maternal plasma angiogenic index-1 (placental growth factor\/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study","volume":"214","author":"Korzeniewski","year":"2016","journal-title":"Am. J. obstetrics Gynecol."},{"issue":"6","key":"10.1016\/j.placenta.2017.02.011_bib25","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.115.05883","article-title":"Placental-Specific sFLT-1 e15a protein is increased in Ppreeclampsia, antagonizes vascular endothelial growth factor signaling, and has antiangiogenic activity","volume":"66","author":"Palmer","year":"2015","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.placenta.2017.02.011_bib26","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/jc.2003-030528","article-title":"Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences","volume":"88","author":"Tsatsaris","year":"2003","journal-title":"J.\u00a0Clin. Endocrinol. metabolism"},{"key":"10.1016\/j.placenta.2017.02.011_bib27","first-page":"1","article-title":"The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia","author":"Chaiworapongsa","year":"2015","journal-title":"J.\u00a0Matern. Fetal Neonatal Med."},{"issue":"3","key":"10.1016\/j.placenta.2017.02.011_bib28","first-page":"241","article-title":"Pre-eclampsia: a complex and variable disease","volume":"4","author":"Redman","year":"2014","journal-title":"Pregnancy Hypertens."},{"issue":"8","key":"10.1016\/j.placenta.2017.02.011_bib29","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3109\/14767058.2015.1048431","article-title":"The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia","volume":"29","author":"Chaiworapongsa","year":"2016","journal-title":"J.\u00a0Matern. Fetal Neonatal Med."},{"issue":"1","key":"10.1016\/j.placenta.2017.02.011_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajog.2005.07.049","article-title":"Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia","volume":"195","author":"Ness","year":"2006","journal-title":"Am. J. obstetrics Gynecol."},{"issue":"10","key":"10.1016\/j.placenta.2017.02.011_bib31","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.placenta.2017.02.011_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/10641955.2012.704107","article-title":"Smoking during pregnancy: changes in mid-gestation angiogenic factors in women at risk of developing preeclampsia according to uterine artery Doppler findings","volume":"32","author":"Llurba","year":"2013","journal-title":"Hypertens. Pregnancy"},{"issue":"8","key":"10.1016\/j.placenta.2017.02.011_bib33","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ajh.2008.219","article-title":"Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia","volume":"21","author":"Jeyabalan","year":"2008","journal-title":"Am. J. Hypertens."},{"issue":"9","key":"10.1016\/j.placenta.2017.02.011_bib34","doi-asserted-by":"crossref","first-page":"e106502","DOI":"10.1371\/journal.pone.0106502","article-title":"Carbon monoxide prevents hypertension and proteinuria in an adenovirus sFlt-1 preeclampsia-like mouse model","volume":"9","author":"Venditti","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.placenta.2017.02.011_bib35","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1172\/JCI80457","article-title":"Excess placental secreted frizzled-related protein 1 in maternal smokers impairs fetal growth","volume":"125","author":"Wang","year":"2015","journal-title":"J.\u00a0Clin. Invest"},{"issue":"3","key":"10.1016\/j.placenta.2017.02.011_bib36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/uog.15879","article-title":"First-trimester screening with specific algorithms for early- and late-onset fetal growth restriction","volume":"48","author":"Crovetto","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2017.02.011_bib37","article-title":"Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction","author":"Kwiatkowski","year":"2016","journal-title":"J.\u00a0Perinat. Med."},{"issue":"1","key":"10.1016\/j.placenta.2017.02.011_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1210\/jc.2007-1042","article-title":"Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction","volume":"93","author":"Nevo","year":"2008","journal-title":"J.\u00a0Clin. Endocrinol. metabolism"},{"issue":"4","key":"10.1016\/j.placenta.2017.02.011_bib39","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1479-828X.1995.tb02144.x","article-title":"Low dose aspirin for the treatment of fetal growth restriction: a randomized controlled trial","volume":"35","author":"Newnham","year":"1995","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"5","key":"10.1016\/j.placenta.2017.02.011_bib40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1471-0528.2010.02879.x","article-title":"Research into Advanced Fetal D and Therapy G. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction","volume":"118","author":"von Dadelszen","year":"2011","journal-title":"BJOG"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400417301546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400417301546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:54:33Z","timestamp":1758909273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400417301546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":40,"alternative-id":["S0143400417301546"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2017.02.011","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placental soluble fms-like tyrosine kinase expression in small for gestational age infants and risk for adverse outcomes","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2017.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}